Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall

Agilent Technologies A reported first-quarter fiscal 2025 earnings of $1.36 per share, which missed the Zacks Consensus Estimate by 0.52%. The figure increased 3.8% year over year.

Revenues of $1.8 billion surpassed the Zacks Consensus Estimate by 0.27%. The top line increased 7% on a reported basis and 4.4% on a core basis (excluding acquisitions and divestitures) year over year.

Agilent shares are down 0.06% in the pre-market trading.

Agilent’s Q1 Top-Line Details

The company operates through three reporting segments—Life Sciences and Diagnostics Markets Group (“LDG”), Agilent CrossLab Group (“ACG”) and Applied Markets Group (“AMG”).

Agilent Technologies, Inc. Price, Consensus and EPS Surprise

Agilent Technologies, Inc. price-consensus-eps-surprise-chart | Agilent Technologies, Inc. Quote

LDG: The segment generated $679 million and accounted for 37.8% of the company’s total revenues. This represented a 5% increase on a reported basis and a 3% rise on a core basis year over year.

ACG: Revenues from the segment were $758 million, accounting for 42.2% of the total revenues. The top line grew 9% on a reported basis and 6% on a core basis year over year.

AMG: Revenues increased 7% year over year to $361 million on a reported and 4% on a core basis, accounting for the remaining 20.1% of the total revenues.

Agilent’s Q1 Operating Results

For the first quarter of fiscal 2026, the LDG segment’s gross margin contracted 230 basis points (bps) year over year to 50.5%. ACG’s gross margin decreased 90 bps year over year to 55.2%, while AMG’s gross margin declined 70 bps year over year to 56.5%.

Research and development (R&D) expenses on a non-GAAP basis were $117 million, up 4.5% from the prior-year quarter. Selling, general and administrative (SG&A) expenses on a non-GAAP basis rose to $406 million, marking a 5.2% increase from the prior-year quarter.
 
As a percentage of revenues, R&D expenses fell 20 bps year over year to 6.5%, while SG&A expenses fell 40 bps year over year to 22.6%.

The non-GAAP operating margin of 24.6% for the fiscal first quarter contracted 50 bps on a year-over-year basis.

Segment-wise, LDG operating margin decreased 200 bps year over year to 16.1%. ACG’s operating margin fell 10 bps year over year to 31.7%. Meanwhile, AMG’s operating margin contracted 90 bps year over year to 25.8%.

A’s Balance Sheet Details

As of Jan. 31, 2026, Agilent’s cash and cash equivalents were $1.75 billion, up from $1.78 billion as of Oct. 31, 2025.

The long-term debt was $3.05 billion as of Jan. 31, 2026, unchanged from the previous quarter.

Agilent’s Q2 & FY26 Guidance

For the second quarter of fiscal 2026, Agilent expects revenues in the range of $1.79-$1.82 billion, indicating a rise of 7% to 9% on a reported basis and 4% to 5.5% on a core basis. Non-GAAP earnings are expected to be between $1.39 per share and $1.42 per share.
 
For fiscal 2026, Agilent expects revenues between $7.3 billion and $7.5 billion, implying an increase of 5.5-7.5% on a reported basis and 4-6% on a core basis. The company expects non-GAAP earnings between $5.90 per share and $6.04 per share.

A’s Zacks Rank & Stocks to Consider

Currently, Agilent carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader Zacks Computer and Technology sector are ATN International ATNI, Broadcom AVGO, and Credo Technology CRDO. While Credo Technology sports a Zacks Rank #1 (Strong Buy), ATN International and Broadcom carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

ATN International is set to report fourth-quarter 2025 results on March 5. ATN International shares have surged 76.4% in the trailing six-month period.

Broadcom is slated to report first-quarter fiscal 2026 results on March 4. Broadcom shares have gained 11.5% in the trailing six-month period.

Credo Technology is set to report third-quarter fiscal 2026 results on March 2. Credo Technology shares have gained 2.8% in the trailing six-month period.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research